Ropizine, also known as SC-13504, is a benzhydryl piperazine compound with notable anticonvulsant properties. Ropizine acts as an allosteric modifier, decreasing the dissociation rate of [3H]DM, which contributes to its anticonvulsant effects.
Research indicates that Ropizine may play a role in the proliferation of PDGFRα+ cells through the PI3K/Akt signaling pathway, particularly in the context of diabetic conditions. This suggests its potential in understanding and addressing complications related to diabetes, such as slow transit constipation.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Ropizine, Ropizina |
|---|---|
| IUPAC Name | (E)-N-(4-benzhydrylpiperazin-1-yl)-1-(6-methylpyridin-2-yl)methanimine |
| CAS | 3601-19-2 |
| Molecular Weight | 370.5 |
| Molecular Formula | C24H26N4 |
| SMILES | CC1=NC(=CC=C1)/C=N/N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4 |